Development of sarcoidosis during anti-TNF-α treatment: What is the mechanism?

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 1054-

  Shin, J I ^a   Kim, Dong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 2; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CYTOKINE PRODUCTION; DISEASE COURSE; GRANULOMA; HUMAN; IN VIVO STUDY; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649112390     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. TOUSSIROT E, PERTUISET E, KANTELIP B, WENDLING D: Sarcoidosis occurring during anti-TNFalpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 2008; 26: 471-5.
2. XAUS J, BESALDUCH N, COMALADA M et al.: High expression of p21 Wafl in sarcoid granulomas: a putative role for long-lasting inflammation. J Leukoc Biol 2003; 74: 295-301.
3. LAWRENCE T, GILROY DW, COLVILLE-NASH PR, WILLOUGHBY DA: Possible new role for NFkappaB in the resolution of inflammation. Nat Med 2001; 7: 1291-7.
4. SAKLATVALA J, DEAN J, CLARK A: Control of the expression of inflammatory response genes. Biochem Soc Symp 2003; 70: 95-106.
5. MOLLER DR: Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 24-31.
6. VERRECCHIA F, PESSAH M, ATFI A, MAUVIEL A: Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem 2000; 275: 30226-31.
7. SALEZ F, GOSSET P, COPIN MC, LAMBLIN DEGROS C, TONNEL AB, WALLAERT B: Transforming growth factor-beta1 in sarcoidosis. Eur Respir J 1998; 12: 913-9.